Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A0LD6E6
Thu, 05.06.2025
Gerresheimer AG
Gerresheimer AG: Annual General Meeting approves key proposed resolutions by a large majority
2024: Progress on key strategic topics
Long-term outlook remains positve thanks to the successfull transformation into a system and solution provider
Dividend of EUR 0.04 per share
Duesseldorf, June 5, 2025. The Annual General Meeting of Gerresheimer AG [ … ]
Mon, 02.06.2025
Gerresheimer AG
Gerresheimer Adjusts Guidance for Financial Year 2025
Preliminary results for Q2 2025: Low-single-digit organic revenue growth, adjusted EBITDA margin around 19%
Continued subdued demand in the cosmetics market
Temporary decline in demand for containment solutions for oral liquid medications
New dividend proposal of 4% of share capital
Long-te [ … ]
Mon, 12.05.2025
Gerresheimer AG
Gerresheimer Successfully Completes Investment in State-of-the-Art Glass Production Facility in Lohr
New oxy-hybrid furnace reduces CO2e emissions by up to 40%
Latest production technology and environmentally friendly cooling system
Capacity expansion to support planned growth
Total investment volume of approximately 100 million euros
Duesseldo [ … ]
Fri, 11.04.2025
Gerresheimer AG
Gerresheimer: Bormioli Pharma boosts revenues and earnings
Revenues +11.6%, Adjusted EBITDA +13.1%
Organic development compared to pro forma figures Q1 2024: revenues -6.5%, adjusted EBITDA -9.3%
Q1 significantly influenced by revenue shift in syringe business
Guidance 2025 confirmed: organic revenue growth of 3-5% and adjusted EBITDA margin of [ … ]
Wed, 26.02.2025
Gerresheimer AG
Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
Organic growth: revenue +2.9%, adjusted EBITDA +4.1%
Destocking in vial business partially offset by strong growth in medical devices
Growth strategy execution: capacity expansions and higher revenue share from solutions for biologics
Bormioli Pharma to boos [ … ]